📰 Jake Goble News
Jake Goble News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Jake Goble. Real-time updates on events, politics, business and more.
October 17, 2023
/PRNewswire/ -- W. L. Gore & Associates (Gore) announces that patients have passed through the multi-month enhanced screening process and have begun entering...
April 24, 2023
SDSU defeats St. Thomas 8-5 and 7-0 on Sunday
April 1, 2023
SDSU drops first game 10-2 before winning second 9-8
March 29, 2023
Product Pairing Offers an Impactful Partnership for Bariatric Surgery...
March 29, 2023
Product Pairing Offers an Impactful Partnership for Bariatric SurgeryWAYNE, Pa., March 29, 2023 -- Teleflex Incorporated , a leading global provider of medical technologies, today announced a... | March 29, 2023
November 1, 2022
The Gore RELIEF study is evaluating the safety and efficacy of transcatheter closure of patent foramen ovale (PFO) with the GORE ® CARDIOFORM Septal Occluder for the relief of migraine headaches.
January 20, 2022
After a decade of clinical use* and more than 50,000 devices sold globally, the GORE CARDIOFORM Septal Occluder continues a trusted legacy of safely advancing care. FLAGSTAFF, Ariz., Jan.
January 19, 2022
After a decade of clinical use* and more than 50,000 devices sold globally, the GORE® CARDIOFORM Septal Occluder continues a trusted legacy of safely advancing care. FLAGSTAFF, Ariz., Jan. 19, 2022 /PRNewswire/ -- W. L. Gore & Associates (Gore) today announced that the GORE® CARDIOFORM Septal Occluder has achieved 10 years of clinical use, treating patients through clinical...
January 19, 2022
/PRNewswire/ -- W. L. Gore & Associates (Gore) today announced that the GORE® CARDIOFORM Septal Occluder has achieved 10 years of clinical use, treating...
January 19, 2022
/PRNewswire/ -- W. L. Gore & Associates (Gore) today announced that the GORE® CARDIOFORM Septal Occluder has achieved 10 years of clinical use, treating...